Latest News about FDA
Recent news which mentions FDA
Cannabis Stocks Soar As Gov Health Officials Call On DEA To Reschedule Marijuana: Is Legalization In Sight?
August 30, 2023
From Benzinga
EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
August 30, 2023
Tickers
ALZN
From Benzinga
Bristol Myers' Expanded Approval For Anemia Drug, Shows Superior Efficacy Over Concurrent Blood Transfusion
August 29, 2023
Tickers
BMY
From Benzinga
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year
August 29, 2023
Tickers
ABT
From Benzinga
Regulatory Setback For Medtronic's High Blood Pressure Device - FDA Backed Japanese Firms' Similar Device For Uncontrolled Hypertension
August 24, 2023
From Benzinga
Individuals With Uncontrolled Hypertension - FDA Adcomm Panel Just Supported Japanese MedTech's Blood Pressure Treatment Device
August 23, 2023
From Benzinga
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
From Benzinga
Congress's Big Hemp And CBD Debate: Safety Or Profit At Stake?
August 21, 2023
From Benzinga
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Tickers
REGN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.